Q3 2026 13F filing
Updated 6 days ago45 disclosed positions worth $418.5M
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | H IMMUNITYBIO INC | $28.3M | 3.00M | 6.77% | — |
| 2 | V VERA THERAPEUTICS INC | $26.1M | 808.7K | 6.24% | — |
| 3 | V VOR BIOPHARMA INC | $21.5M | 1.13M | 5.14% | — |
| 4 | A AMYLYX PHARMACEUTICALS INC | $20.4M | 700.0K | 4.87% | — |
| 5 | S SAGIMET BIOSCIENCES INC | $19.4M | 1.96M | 4.63% | — |
| 6 | D DEFINIUM THERAPEUTICS INC | $19.4M | 508.7K | 4.63% | — |
| 7 | I IONIS PHARMACEUTICALS INC | $18.8M | 420.0K | 4.48% | — |
| 8 | G GENMAB A/S | $18.7M | 525.0K | 4.48% | — |
| 9 | S SOL-GEL TECHNOLOGIES LTD | $17.8M | 239.2K | 4.25% | — |
| 10 | Z ZURA BIO LTD | $17M | 4.08M | 4.05% | — |
| 11 | L LB PHARMACEUTICALS INC | $15.8M | 410.4K | 3.76% | — |
| 12 | A ABIVAX SA | $15.3M | 155.0K | 3.67% | — |
| 13 | A ANNEXON INC | $14.8M | 3.50M | 3.54% | — |
| 14 | B BELITE BIO INC | $12.7M | 75.0K | 3.04% | — |
| 15 | E EUPRAXIA PHARMACEUTICALS INC | $10.9M | 1.20M | 2.61% | — |
| 16 | N NEKTAR THERAPEUTICS | $10.6M | 175.0K | 2.53% | — |
| 17 | M MOONLAKE IMMUNOTHERAPEUTICS | $10M | 855.8K | 2.39% | — |
| 18 | ? N/A CLIMB BIO INC | $9.2M | 800.0K | 2.19% | — |
| 19 | A ABCELLERA BIOLOGICS INC | $8.8M | 600.0K | 2.09% | — |
| 20 | N NEUROGENE INC | $8.3M | 300.0K | 1.99% | — |
| 21 | C COMPASS PATHWAYS PLC | $6.2M | 500.0K | 1.49% | — |
| 22 | J JATT II ACQUISITION CORP | $5.6M | 500.0K | 1.34% | — |
| 23 | I INFLARX NV | $5.5M | 3.05M | 1.31% | — |
| 24 | R RESEARCH ALLIANCE CORP III | $5.5M | 504.9K | 1.31% | — |
| 25 | D BRIGHT MINDS BIOSCIENCES INC | $5.5M | 109.6K | 1.30% | — |
| 26 | A AMANAT ACQUISITION CORP | $5.3M | 500.0K | 1.28% | — |
| 27 | ? N/A ALTIMMUNE INC | $5M | 1.74M | 1.19% | — |
| 28 | J JATT III ACQUISITION CORP | $5M | 450.0K | 1.19% | — |
| 29 | P PHARVARIS N V | $4.8M | 150.0K | 1.14% | — |
| 30 | S SCYNEXIS INC | $4.7M | 944.3K | 1.11% | — |
| 31 | C CULLINAN THERAPEUTICS INC | $4.6M | 300.0K | 1.10% | — |
| 32 | C CONTINEUM THERAPEUTICS INC | $4M | 300.0K | 0.96% | — |
| 33 | H CYBIN INC | $3.9M | 321.0K | 0.94% | — |
| 34 | R REZOLUTE INC | $3.9M | 951.8K | 0.94% | — |
| 35 | I OPUS GENETICS INC | $3.8M | 776.9K | 0.90% | — |
| 36 | E ENLIVEN THERAPEUTICS INC | $3.2M | 70.0K | 0.77% | — |
| 37 | R RELMADA THERAPEUTICS INC | $3.2M | 842.1K | 0.76% | — |
| 38 | D DBV TECHNOLOGIES S A | $2.9M | 250.0K | 0.70% | — |
| 39 | E EVOMMUNE INC | $2.7M | 325.0K | 0.64% | — |
| 40 | C CONTINEUM THERAPEUTICS INC | $2.5M | 186.2K | 0.60% | — |
| 41 | O ORUKA THERAPEUTICS INC | $2.1M | 24.6K | 0.49% | — |
| 42 | H HUMACYTE INC | $1.9M | 3.75M | 0.46% | — |
| 43 | ? N/A REIN THERAPEUTICS INC | $1.3M | 1.66M | 0.32% | — |
| 44 | R RESEARCH ALLIANCE CORP IV | $1.3M | 106.4K | 0.31% | — |
| 45 | A ANNEXON INC | $412K | 97.3K | 0.10% | — |